Reports
Rates
Non-Members
Price: €35.00 (UK €41.13 inc. VAT)
Science|Business Members
Price: FREE

Make sure you login to get this price.

Is your organisation a member? Check here.
If so, click here to find out how to receive your copy.
Support
Please contact us at orders@sciencebusiness.net or +32 2304 7577 if you need any assistance.
Pages: 48
Health for All, Care for You (PDF)

Science|Business and Sweden’s Karolinska Institutet have conducted a survey of a wide range of stakeholders in personalised healthcare across four major EU-markets (Belgium, France, the Netherlands and the UK).

info

info
Science|Business and Sweden’s Karolinska Institutet have conducted a survey of a wide range of stakeholders in personalised healthcare across four major EU-markets (Belgium, France, the Netherlands and the UK).
The story of personalised healthcare is a classic case of the difficulties of getting a game changing technology from lab to market. Specialists in the field agree: It is powerful, important, destabilising, disruptive. But a host of problems slow its deployment into mainstream medicine.
Personalised medicine holds enormous potential, but European healthcare professionals foresee many problems to be overcome before that potential can be realised. This reports brings you the Karolinska survey’s key results, presented along with ideas which emerged from a discussion of the issues identified in the work.